Carbon-11 Labeled Sarcosine in Prostate Cancer

• Status: Completed
• Trial end date: 2017-02-08
• Target enrollment: 0
• Participant gender: Male

Summary

Men with and without prostate cancer will have a PET/CT scan that measures the level of the amino acid sarcosine. PET is a scanning method that uses short lived radioactivity.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Michigan
• Collaborators: National Cancer Institute (NCI); National Institutes of Health (NIH)
• Treatments: Choline

Criteria

Inclusion Criteria:

• Males 40 years of age or older

• Confirmed or suspected prostate cancer and will undergo a planned tissue biopsy of the known or suspected tumor (Prostate Cancer Group 1 only)

Exclusion Criteria:

• Active malignancy (except basal cell or squamous cell skin cancer) within the last 2 years

• Body weight > 350 lbs (158 kg)

• Prisoners

• Subject not willing or able to sign informed consent